ROBOT Report - pbpko

Download TSV

Types of errors

LevelNumber of errors
WARN48
INFO12
ERROR8

Error breakdown

RuleNumber of errors
annotation_whitespace28
missing_definition20
missing_superclass7
duplicate_definition6
lowercase_definition5
label_whitespace2

Click on any term to redirect to the term page.

Row Level Rule Name Subject Property Value
0 ERROR duplicate_definition obo:PBPKO_00374 IAO:0000115 Volume of placenta
1 ERROR duplicate_definition obo:PBPKO_00380 IAO:0000115 Volume of placenta
2 ERROR duplicate_definition obo:PBPKO_00176 IAO:0000115 Partition_coefficient of skin to plasma
3 ERROR duplicate_definition obo:PBPKO_00516 IAO:0000115 Partition_coefficient of skin to plasma
4 ERROR duplicate_definition obo:PBPKO_00055 IAO:0000115 Fraction of cardiac output in the portal vein
5 ERROR duplicate_definition obo:PBPKO_00057 IAO:0000115 Fraction of cardiac output in the portal vein
6 ERROR label_whitespace obo:PBPKO_00007 rdfs:label Body_Mass_Index
7 ERROR label_whitespace obo:PBPKO_00304 rdfs:label Vmax_baso_in_vitro
8 WARN annotation_whitespace obo:PBPKO_00008 IAO:0000115 Mass or quantity of heaviness of an individual.
9 WARN annotation_whitespace obo:PBPKO_00060 IAO:0000115 Fractions of total blood flow
10 WARN annotation_whitespace obo:PBPKO_00066 IAO:0000115 Organ volume in pbpk modeling refers to the volume of a specific organ or tissue in the body.
11 WARN annotation_whitespace obo:PBPKO_00115 IAO:0000115 Volume of the gallbaldder
12 WARN annotation_whitespace obo:PBPKO_00130 IAO:0000115 Ratio of a dissolved xenoboitic substance in a two-phase system.
13 WARN annotation_whitespace obo:PBPKO_00137 IAO:0000115 A molecular entity that can undergo oxidation by the loss of hydrogen atom(s).
14 WARN annotation_whitespace obo:PBPKO_00186 skos:exactMatch http://purl.bioontology.org/ontology/SNOMEDCT/17003006
15 WARN annotation_whitespace obo:PBPKO_00210 IAO:0000115 First pass metabolism, also known as the first pass effect or presystemic metabolism, is a phenomenon in which a drug/chemical undergoes metabolism at a specific location in the body, resulting in a reduced concentration of the active drug/chemical before it reaches its site of action or systemic circulation.
16 WARN annotation_whitespace obo:PBPKO_00216 IAO:0000115 Kd in pbpk modeling refers to the dissociation constant of a drug/chemical-receptor complex, which is a measure of the affinity of the drug/chemical for its target receptor. it affects the distribution and elimination of the drug/chemical in the body. the dissociation constant (kd) is defined as the ratio of the rate constants for the forward and reverse reactions of the drug/chemical-receptor complex.
17 WARN annotation_whitespace obo:PBPKO_00229 IAO:0000115 Volume of fluid cleared of xenoboitic from body per unit time.
18 WARN annotation_whitespace obo:PBPKO_00230 IAO:0000115 Fecal cleared volume of xenoboitic from body per unit time.
19 WARN annotation_whitespace obo:PBPKO_00231 IAO:0000115 Sweat cleared volume of xenoboitic from body per unit time.
20 WARN annotation_whitespace obo:PBPKO_00232 IAO:0000115 Urine cleared volume of xenoboitic from body per unit time.
21 WARN annotation_whitespace obo:PBPKO_00233 IAO:0000115 Bile cleared volume of xenoboitic from body per unit time.
22 WARN annotation_whitespace obo:PBPKO_00234 IAO:0000115 Liver cleared volume of xenoboitic from body per unit time.
23 WARN annotation_whitespace obo:PBPKO_00263 IAO:0000115 Bioavailability is defined as the rate and extent to which the active ingredient or active moiety is absorbed from a xenoboitic product and becomes available at the site of action (us-fda, cder, 2014a).
24 WARN annotation_whitespace obo:PBPKO_00319 IAO:0000115 A one-compartment model assumes that all the tissues in the body are contained in a single compartment called the central compartment.
25 WARN annotation_whitespace obo:PBPKO_00345 IAO:0000115 Inter-individual differences in anatomical and physiological characteristics
26 WARN annotation_whitespace obo:PBPKO_00387 IAO:0000115 Measure of the age of a pregcy, indicating how far along the pregcy is. typically measured in weeks
27 WARN annotation_whitespace obo:PBPKO_00388 IAO:0000115 Measure of the week of a pregcy, indicating how far along the pregcy is.
28 WARN annotation_whitespace obo:PBPKO_00390 IAO:0000115 Rate at which drug/chemical transfer from materal circulation to amniotic fluid
29 WARN annotation_whitespace obo:PBPKO_00441 IAO:0000115 Physiological barrier that separates the blood and milk compartments in lactating species.
30 WARN annotation_whitespace obo:PBPKO_00474 IAO:0000115 It is one long tube continuing from small intestine and includes colon, rectum and anus
31 WARN annotation_whitespace obo:PBPKO_00494 IAO:0000115 It is lengthy, upper part of large intestine
32 WARN annotation_whitespace obo:PBPKO_00529 IAO:0000115 Qfiltrate is a parameter used in pbpk modeling to describe the blood flow rate to the filtrate which is used to calculate the rate of drug/chemical delivery to the filtrate.
33 WARN annotation_whitespace obo:PBPKO_00531 IAO:0000115 Qgut is a parameter used in pbpk modeling to describe the blood flow rate to the gut which is used to calculate the rate of drug/chemical delivery to the gut.
34 WARN annotation_whitespace obo:PBPKO_00532 IAO:0000115 Qmam is a parameter used in pbpk modeling to describe the blood flow rate to the mammary gland which is used to calculate the rate of drug/chemical delivery to the mammary gland.
35 WARN annotation_whitespace obo:PBPKO_00550 IAO:0000115 Amount of substance in the adipose tissue
36 WARN missing_definition obo:PBPKO_00135 IAO:0000115
37 WARN missing_definition obo:PBPKO_00312 IAO:0000115
38 WARN missing_definition obo:PBPKO_00447 IAO:0000115
39 WARN missing_definition obo:PBPKO_00459 IAO:0000115
40 WARN missing_definition obo:PBPKO_00485 IAO:0000115
41 WARN missing_definition obo:PBPKO_00500 IAO:0000115
42 WARN missing_definition obo:PBPKO_00505 IAO:0000115
43 WARN missing_definition obo:PBPKO_00512 IAO:0000115
44 WARN missing_definition obo:PBPKO_00520 IAO:0000115
45 WARN missing_definition obo:PBPKO_00523 IAO:0000115
46 WARN missing_definition obo:PBPKO_00526 IAO:0000115
47 WARN missing_definition obo:PBPKO_00527 IAO:0000115
48 WARN missing_definition obo:PBPKO_00528 IAO:0000115
49 WARN missing_definition obo:PBPKO_00530 IAO:0000115
50 WARN missing_definition obo:PBPKO_00533 IAO:0000115
51 WARN missing_definition obo:PBPKO_00534 IAO:0000115
52 WARN missing_definition obo:PBPKO_00535 IAO:0000115
53 WARN missing_definition obo:PBPKO_00536 IAO:0000115
54 WARN missing_definition obo:PBPKO_00537 IAO:0000115
55 WARN missing_definition obo:PBPKO_00545 IAO:0000115
56 INFO lowercase_definition obo:PBPKO_00137 IAO:0000115 A molecular entity that can undergo oxidation by the loss of hydrogen atom(s).
57 INFO lowercase_definition obo:PBPKO_00263 IAO:0000115 Bioavailability is defined as the rate and extent to which the active ingredient or active moiety is absorbed from a xenoboitic product and becomes available at the site of action (us-fda, cder, 2014a).
58 INFO lowercase_definition obo:PBPKO_00387 IAO:0000115 Measure of the age of a pregcy, indicating how far along the pregcy is. typically measured in weeks
59 INFO lowercase_definition obo:PBPKO_00388 IAO:0000115 Measure of the week of a pregcy, indicating how far along the pregcy is.
60 INFO lowercase_definition obo:PBPKO_00440 IAO:0000115 pH of milk
61 INFO missing_superclass obo:PBPKO_00000 rdfs:subClassOf
62 INFO missing_superclass obo:PBPKO_00002 rdfs:subClassOf
63 INFO missing_superclass obo:PBPKO_00003 rdfs:subClassOf
64 INFO missing_superclass obo:PBPKO_00217 rdfs:subClassOf
65 INFO missing_superclass obo:PBPKO_00443 rdfs:subClassOf
66 INFO missing_superclass obo:PBPKO_00444 rdfs:subClassOf
67 INFO missing_superclass obo:PBPKO_00446 rdfs:subClassOf